These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 913860)

  • 21. Pharmacokinetics of amikacin in patients with renal insufficiency: relation of half-life and creatinine clearance.
    Pijck J; Hallynck T; Soep H; Baert L; Daneels R; Boelaert J
    J Infect Dis; 1976 Nov; 134 SUPPL():S331-41. PubMed ID: 993626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacokinetics of amikacin in bronchial secretions].
    Even P; Bergogne-Berezin E; Reynaud P; Berthelot G
    Nouv Presse Med; 1979 Oct; 8(42):3441-4. PubMed ID: 537891
    [No Abstract]   [Full Text] [Related]  

  • 23. Pharmacokinetics of amikacin in pony foals after a single intramuscular injection.
    Brown MP; Gronwall RR; Martinez DS; Beal C
    Am J Vet Res; 1986 Feb; 47(2):453-4. PubMed ID: 3954234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of amikacin (BB-K8) in patients undergoing hemodialysis.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Sanchez Tomero JA
    Int J Clin Pharmacol Biopharm; 1979 Aug; 17(8):357-60. PubMed ID: 489203
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Blood level of amikacin after drip intravenous infusion (author's transl)].
    Sawae Y; Takii M
    Jpn J Antibiot; 1980 Apr; 33(4):539-48. PubMed ID: 7411857
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical pharmacokinetics of amikacin in dogs.
    Baggot JD; Ling GV; Chatfield RC
    Am J Vet Res; 1985 Aug; 46(8):1793-6. PubMed ID: 4037511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of amikacin in patients with normal or impaired renal function: radioenzymatic acetylation assay.
    Plantier J; Forrey AW; O'Neill MA; Blair AD; Christopher TG; Cutler RE
    J Infect Dis; 1976 Nov; 134 SUPPL():S323-30. PubMed ID: 993625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of peritoneal dialysis of the pharmacokinetics of amikacin.
    Matzke GR; Salem N; Bockbrader H; Blevins R
    Proc Clin Dial Transplant Forum; 1980; 10():302-4. PubMed ID: 7346850
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of ototoxicity of amikacin (BB-K8) by animal test (author's transl)].
    Akiyoshi M; Sato K; Nakada H; Tajima T; Suzuki K
    Jpn J Antibiot; 1975 Jun; 28(3):288-304. PubMed ID: 1152283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disposition studies with amikacin after rapid intravenous and intramuscular administration to human volunteers.
    Yates RA; Mitchard M
    J Antimicrob Chemother; 1978 Jul; 4(4):335-41. PubMed ID: 690033
    [No Abstract]   [Full Text] [Related]  

  • 31. [Absorption, excretion and distribution of amikacin following intravenous drip infusion. Intravenous drip infusion, one shot intravenous injection and intramuscular administration of amikacin in dogs, rabbits and rats].
    Matsumoto H; Ochiai K; Nakajima A; Matsuzaki M
    Jpn J Antibiot; 1982 Aug; 35(8):2034-46. PubMed ID: 7154249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amikacin levels in the human biliary tract.
    LeFrock JL; Schell RF; Siskind S; Carr BB
    J Clin Pharmacol; 1984; 24(5-6):247-54. PubMed ID: 6747021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the pharmacokinetics of amikacin and gentamicin.
    Wise R; Walker JM; Mitchard M
    J Antimicrob Chemother; 1981 Jul; 8 Suppl A():45-9. PubMed ID: 7263565
    [No Abstract]   [Full Text] [Related]  

  • 34. Ototoxicity and pharmacokinetically determined dosages of amikacin in granulocytopenic cancer patients.
    Danhauer FJ; Fortner CL; Schimpff SC; deJongh CA; Wesley MN; Wiernik PH
    Clin Pharm; 1982; 1(6):539-43. PubMed ID: 7185540
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical results with amikacin (BB-K8) in surgical field (author's transl)].
    Fujimoto M; Hirao S; Ueda T; Sakai K; Shiraha Y
    Jpn J Antibiot; 1974 Apr; 27(2):234-7. PubMed ID: 4546598
    [No Abstract]   [Full Text] [Related]  

  • 36. [Teratological studies of amikacin (BB-K8) in rabbit (author's transl)].
    Matsuzaki M; Akutsu S; Mukogawa H; Aizawa T
    Jpn J Antibiot; 1975 Jun; 28(3):366-71. PubMed ID: 1152290
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on the toxicity of amikacin (BB-K8). Chronic toxicity in dogs (author's transl)].
    Matsuzaki M; Yoshida A; Akutsu S; Nakamura K; Sekino M
    Jpn J Antibiot; 1975 Aug; 28(4):485-524. PubMed ID: 1160144
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of dermatological cases with BB-K8 (author's transl)].
    Kameyama A; Maruta H; Minami K
    Jpn J Antibiot; 1975 Aug; 28(4):525-9. PubMed ID: 808656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Fundamental and clinical studies on amikacin (BB-K8) in complicated urinary tract infections (author's transl)].
    Mita T; Mayumi K; Kataoka N; Ishigami J
    Jpn J Antibiot; 1977 Mar; 30(3):215-22. PubMed ID: 404447
    [No Abstract]   [Full Text] [Related]  

  • 40. Influence of the route of administration on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Corbacho L
    Eur J Clin Pharmacol; 1981; 19(5):367-70. PubMed ID: 7238565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.